Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.4750 (-0.37%) ($9.4750 - $9.4750) on Mon. Dec. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.8% (three month average) | RSI | 41 | Latest Price | $9.4750(-0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(58%) IWC(53%) IWO(49%) IWM(48%) IWN(46%) | Factors Impacting EDIT price | EDIT will decline at least -2.4% in a week (0% probabilities). VIXM(-13%) VXX(-9%) XBI(-7%) XME(-5%) XLU(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.4% (StdDev 4.8%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.06(-195.62%) | Resistance Level | $10.46 | 5 Day Moving Average | $9.71(-2.42%) | 10 Day Moving Average | $9.9(-4.29%) | 20 Day Moving Average | $10.46(-9.42%) | To recent high | -41.1% | To recent low | 0% | Market Cap | $588m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |